ClinConnect ClinConnect Logo
Search / Trial NCT05993845

Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty

Launched by PHILIPP FÜRNSTAHL · Aug 7, 2023

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Surgery Recording Arthroplasty Surgical Process Modelling

ClinConnect Summary

This clinical trial is studying a specific type of hip surgery called total hip arthroplasty (THA), using a technique known as the direct anterior approach (DAA). The goal is to create a detailed guide that breaks down the surgical process into clear steps. This will help improve the way surgeries are performed and understood. Researchers will analyze videos of the surgery to identify and label each part of the procedure systematically.

To participate in this trial, you need to be between 65 and 74 years old and undergoing your first total hip replacement surgery at one of the participating hospitals. You will also need to provide complete medical imaging data, like CT scans and X-rays of your hip and pelvis, and sign a consent form. If you have had previous hip surgery at the same site or have certain hip or pelvis fractures, you may not be eligible. Participants can expect to contribute to important research that could enhance surgical techniques and improve outcomes for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary surgery for total hip arthroplasty (THA) at Balgrist University Hospital, Kantonsspital Baden and Kantonsspital Winterthur
  • Complete radiological data (CT and Hip/Pelvis x-ray)
  • Signed consent
  • Exclusion Criteria:
  • Missing or incomplete consent
  • Previous surgery of the hip at the site of the THA
  • Fracture of the hip or pelvis at the site of the THA

About Philipp Fürnstahl

Philipp Fürnstahl is a dedicated clinical trial sponsor known for its commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, the organization collaborates with healthcare professionals and research institutions to facilitate the efficient design and execution of clinical studies. Philipp Fürnstahl prioritizes ethical standards and regulatory compliance, ensuring that all trials are conducted with the highest level of integrity and transparency. Their mission is to contribute to the development of safe and effective treatments that address unmet medical needs, ultimately enhancing the quality of care for patients worldwide.

Locations

Baden, Aargau, Switzerland

Zurich, , Switzerland

Winterthur, Zurich, Switzerland

Patients applied

0 patients applied

Trial Officials

Philipp Fürnstahl, PhD

Principal Investigator

Balgrist University Hospital

Patrick Zingg, MD

Study Chair

Balgrist University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported